Kbc Group Nv Tandem Diabetes Care Inc Transaction History

Kbc Group Nv

$37 Billion
Q2 2025

A detailed history of Kbc Group Nv transactions in Tandem Diabetes Care Inc stock. As of the latest transaction made, Kbc Group Nv holds 191,837 shares of TNDM stock, worth $3.57 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

191,837

Previous 193,808 1.02%

Holding current value

$3.57 Million

Previous $3.71 Million 3.69%

% of portfolio

0.01%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 08, 2025	SELL	$16.35 - $23.52 $32,225 - $46,357	-1,971 Reduced 1.02%	191,837 $3.58 Million
Q1 2025 Apr 25, 2025	BUY	$17.89 - $37.53 $23,775 - $49,877	1,329 Added 0.69%	193,808 $3.71 Million
Q4 2024 Jan 22, 2025	BUY	$27.34 - $41.78 $1.54 Million - $2.36 Million	56,461 Added 41.51%	192,479 $6.93 Million
Q3 2024 Nov 06, 2024	SELL	$35.21 - $47.3 $3.64 Million - $4.89 Million	-103,396 Reduced 43.19%	136,018 $5.77 Million
Q2 2024 Jul 17, 2024	SELL	$30.43 - $53.43 $16,127 - $28,317	-530 Reduced 0.22%	239,414 $9.65 Million

Q4 2023 Feb 13, 2024	BUY	$14.28 - $31.03 $2.46 Million - $5.35 Million	172,570 Added 256.14%	239,944 $7.1 Million
Q3 2023 Feb 15, 2024	BUY	$19.33 - $36.22 $1.2 Million - $2.24 Million	61,940 Added 91.93%	129,314 $2.69 Million
Q2 2023 Feb 15, 2024	BUY	$24.18 - $42.46 $142,033 - $249,410	5,874 Added 9.55%	67,374 $1.65 Million
Q2 2023 Jul 28, 2023	SELL	$24.18 - $42.46 $13,323 - $23,395	-551 Reduced 0.81%	67,374 $1.65 Million
Q1 2023 Feb 14, 2024	BUY	$35.86 - $46.5 $189,197 - $245,334	5,276 Added 8.42%	67,925 $2.76 Million
Q1 2023 May 04, 2023	BUY	$35.86 - $46.5 $230,400 - $298,762	6,425 Added 10.45%	67,925 $2.76 Million
Q4 2022 Feb 14, 2024	BUY	$35.49 - $56.15 $40,778 - $64,516	1,149 Added 1.87%	62,649 $2.82 Million
Q3 2022 Feb 15, 2024	SELL	$43.76 - $68.97 $7.81 Million - $12.3 Million	-178,444 Reduced 74.37%	61,500 $2.94 Million
Q2 2022 Feb 14, 2024	SELL	$53.22 - $123.09 $673,073 - $1.56 Million	-12,647 Reduced 17.06%	61,500 $3.64 Million
Q2 2022 Jul 26, 2022	SELL	$53.22 - $123.09 $673,073 - $1.56 Million	-12,647 Reduced 17.06%	61,500 $3.64 Million
Q1 2022 Feb 14, 2024	SELL	$101.89 - $150.09 $1.6 Million - $2.36 Million	-15,705 Reduced 17.48%	74,147 $8.62 Million
Q1 2022 May 06, 2022	SELL	$101.89 - $150.09 $1.6 Million - $2.36 Million	-15,705 Reduced 17.48%	74,147 $8.62 Million
Q4 2021 Feb 14, 2024	SELL	$118.18 - $153.21 $17.7 Million - $23 Million	-150,092 Reduced 62.55%	89,852 $13.5 Million
Q4 2021 Feb 03, 2022	BUY	$118.18 - $153.21 $3.39 Million - $4.4 Million	28,695 Added 46.92%	89,852 $13.5 Million
Q3 2021 Nov 10, 2021	BUY	$93.51 - $129.4 $5.72 Million - $7.91 Million	61,157 New	61,157 $7.3 Million

Others Institutions Holding TNDM

# of Institutions

287

Shares Held

74.1M

Call Options Held

2.94M

Put Options Held

362K

View Full List

About TANDEM DIABETES CARE INC

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $1.2B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

More about TNDM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.

Account